BRQ and Novo Nordisk Latam improve the patient experience

MASH is still not widely known and is often underdiagnosed. Working with BRQ, Novo Nordisk set out to raise awareness about the condition while also making it easier for people to access exams and specialists.

We adopted an approach of testing on a small scale, learning fast and scaling what creates value. We combined empathetic language, functional CTAs and a useful digital service, aligning communication and access to healthcare in a single solution.

Through the partnership between BRQ and Novo Nordisk, the campaign gained momentum with a simple, digital solution centered on the people who need care. By connecting education and action, we shortened the path to diagnosis and contributed to a more accessible and efficient journey for thousands of people.